CLNICAL TRIALS WARSZAW

PhD

Paula
Śliwińska-Stańczyk

rheumatologist

Education

2004

University Internship at the Faculty of Medicine, University of Geneva March-November 2004

2004

Scientific Internship at the Laboratory of the Department of Clinical Immunology, University Hospital, Geneva

1998

PhD, Institute of Rheumatology, Warsaw, Thesis title: “The Effect of Glucocorticosteroids on the Function of Peripheral Blood Mononuclear Cells in Rheumatoid Arthritis,” Institute of Rheumatology, Warsaw, 1998

1998

Rheumatology Specialist

1994

Internal Medicine Physician

1984-1990

Medical University of Warsaw, Faculty of Medicine

Professional experience

1994-2011

Assistant Professor at the Rheumatology Clinic of the Institute of Rheumatology in Warsaw

1988-1994

Assistant at the Rheumatology Clinic of the Institute of Rheumatology in Warsaw

since 1985

Deputy Head of the 4th Internal Medicine Department at Wolski Hospital

since 1983

Acting Head of the 4th Internal Medicine Department at Wolski

1978-1983

Assistant at the 4th Internal Medicine Department at Wolski Hospital in Warsaw

1977-1978

Postgraduate internship at the Śródmieście Healthcare Center

1993

Additional skills – gastrointestinal endoscopy

Membership

Member of the Polish Rheumatology Society

Achievements

2010

Co-author of the textbook “Rheumatic Symptoms in the Course of Internal Organ Diseases” Termedia Medical Publishing House 2010

1992-2009

Author and co-author of over 30 publications and reports at Polish and international scientific meetings in the field of rheumatology

Over the years

Participation in several international clinical trials on rheumatoid arthritis, psoriatic arthritis, and osteoarthritis

Over the years

Participation in numerous conferences, meetings, congresses, symposia, and training courses in the field of rheumatology

Scientific publications

Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK)

Cindy L J Weinstein, Paula Sliwinska-Stanczyk, Tomas Hála, Marina Stanislav, Anjela Tzontcheva, Ruji Yao, Yuliya Berd, Sean P Curtis, George Philip, Rheumatology, Volume 62, Issue 11, November 2023, Pages 3601–3609

Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial

Philip Mease, Philip Helliwell, Paula Silwinska-Stanczyk, Malgorzata Miakisz, Andrew Ostor, Elena Peeva, Michael S. Vincent, Qiankun Sun, Vanja Sikirica, Randall Winnette, Ruolun Qiu, Gang Li, Gang Feng, Jean S. Beebe, David A. Martin, Arthritis & Rheumatology, August 2023, 1370-1380

Efficacy and Safety of Brepocitinib (Tyrosine Kinase 2/Janus Kinase 1 Inhibitor) for the Treatment of Active Psoriatic Arthritis: Results from a Phase 2b Randomized Controlled Trial.

Philip Mease, Philip S Helliwell, Paula Silwinska-Stanczyk, Malgorzata Miakisz, Andrew Ostor, Elena Peeva, Michael Vincent, Vanja Sikirica, Randall Winnette, Ruolun Qiu, Gang Li, Gang Feng, Jean Beebe and David Martin, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, REUMATIKA – Centrum Reumatologii NZOZ, Warsaw, Poland, Twoja Przychodnia Centrum Medyczne Nowa Sol, Nowa Sol, Poland, Monash University, Cabrini Hospital & Emeritus Research, Melbourne, Australia, Pfizer Inc, Cambridge, MA, Pfizer Inc, Collegeville, PA, Pfizer Inc, New York, NY; ACR Convergence 2021.

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study.

Atul Deodhar, Paula Sliwinska-Stanczyk,Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée van der Heijde.; Annals of Rheumatic Diseases August 2021 Volume 80, 1004-1013.

Tofacitinib for the treatment of adult patients with ankylosing spondylitis: Primary analysis of a phase 3, randomized, double-blind, placebo-controlled study.

A. Deodhar, P. Śliwińska-Stańczyk, H. Xu, X. Baraliakos, L.S. Gensler, D. Fleishaker, L. Wang, J. Wu, S. Menon, C. Wang, O. Dina, L. Fallon, K.S. Kanik, D. van der Heijde; ustna prezentacja podczas ACR 2020 (American College of Rheumatology).

Decreased expression of of integrins by hematopoietic cells in patients with rheumatoid arthritis and anemia: relationship with bone marrow cytokine levels.

J. Jaworski, W. Maślinski, J. Pazdur, P. Śliwinska-Stańczyk, E. Kamińska-Tchórzewska, L. Jung, J.K. Łącki. J Investig Allergol Clin Immunol., 2008; 18(1), 17-21.

The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patient.

Sliwińska-Stańczyk P, Pazdur J, Ziółkowska M, Jaworski J, Kamińska-Tchórzewska E, Łącki J.K. Scand J Rheumatol., 2007; 36, 167-171.

Rheumatoid arthritis in Poland and Lithuania.

Butrimiene, E. Kamińska, K. Valiukiene, P. Śliwińska, E. Kubasiewicz, A. Kozakiewicz, A. Smerdel, V. Kucinskas, J. Jaworski, E. Jastrzębska, O. Forre, A. Venalis, J. Pazdur. Annals of Rheumatic Diseases, 2005; 64, 165-166.

Estimation of efficacy of EMOCHOL-GEL used externally by patients with rheumatoid arthritis and osteoarthritis.

Paula Śliwinska –Stańczyk , Ewa Kamińska –Tchórzewska, Janusz Jaworski. Reumatologia, 2004; 42,1.

The evaluation of aggressive treatment in patients with rheumatoid arthritis.

E. Kamińska –Tchórzewska, P. Śliwinska –Stańczyk, E. Kubasiewicz, I. Baryłka – Morawska, J. Jaworski. Reumatologia, 2001; 39,4.

Wstępna ocena wartości pulsów kortykosteroidowych w leczeniu chorych we wczesnych okresach reumatoidalnego zapalenia stawów.

Ewa Kamińska-Tchórzewska, Paula Śliwińska-Stańczyk, Jacek Pazdur. Reumatologia, 2000; XXXVII,1.

Ocena wskazań do leczenia i zagrożeń wynikających z zastosowania cyklosporyny w reumatoidalnym zapaleniu stawów.

E. Kubasiewicz, P. Śliwińska-Stańczyk, I. Morawska, E. Kamińska-Tchórzewska, J.Jaworski, J. Pazdur. Reumatologia,1999; 37,4.

The assessment of the influence of the methotrexate in early period of rheumatoid arthritis on the prevention of bone destruction in the radiological studies.

E. Kubasiewicz, J. Staniszewska, J. Pazdur, I. Baryłka Morawska, P. Śliwińska – Stańczyk, E. Kamińska-Tchórzewska. Reumatologia,1997; 35,2.

The evaluation of combination therapy with low dosage of methotrexate and corticosteroid pulses.

E. Kubasiewicz, J. Pazdur. I. Morawska, E. Kamińska-Tchórzewska, P. Śliwińska-Stańczyk. Zeitschrift fur Rheumatologie Band 54, Heft 5. 1995.

Przydatność badań klinicznych i laboratoryjnych w prognozowaniu rozwoju niesklasyfikowanego przewlekłego zapalenia stawów.

J. Pazdur, A. Ryżewska, A. Filipowicz-Sosnowska, S. Luft, E. Kubasiewicz, B. Kwiatkowska, I. Baryłka-Morawska, E. Kamińska-Tchórzewska, P. Śliwińska-Stańczyk, M. Ziółkowska, J. Ząbek. Reumatologia, 1994; T.XXXII, 4.